Journal Home
Search for

Volume 30, Issue 10, Pages 2209-2218 (October 2004)


View previous. 63 of 73 View next.

Complications of foldable intraocular lenses requiring explantation or secondary intervention—2003 survey update☆☆

Nick MamalisCorresponding Author Informationemail address, Brandon Davis, MD, Christian D. Nilson, MD, M.Scott Hickman, MD, Russell M. LeBoyer, MD

Accepted 1 June 2004.

Abstract 

The sixth annual survey of complications associated with foldable intraocular lenses (IOLs) requiring explantation or secondary intervention was sent to members of the American Society of Cataract and Refractive Surgery and the European Society of Cataract and Refractive Surgeons. Preoperative data about visual acuity, patient signs and symptoms, and complications requiring IOL removal were evaluated. Complications were then tabulated for each of the following major foldable IOL groups: 3-piece monofocal silicone, 3-piece hydrophobic acrylic, 1-piece hydrophobic acrylic with haptics, 3-piece hydrophilic acrylic (hydrogel), 1-piece hydrophilic acrylic (hydrogel), 1-piece plate-type silicone, 3-piece multifocal silicone, and Collamer. Two hundred seventy-three surveys were returned for evaluation. Dislocation/decentration, incorrect lens power, IOL calcification, and glare/optical aberrations were the most common reasons for removing foldable IOLs. Good surgical technique, accurate IOL power measurements, and high manufacturing standards for foldable IOL materials and designs are the most important factors in avoiding complications with foldable IOLs.

Corresponding Author InformationReprint requests to Nick Mamalis, MD, Moran Eye Center, University of Utah, 50 North Medical Drive, Salt Lake City, Utah 84132, USA.

 Presented in part at the ASCRS Symposium on Cataract, IOL and Refractive Surgery, San Diego, California, USA, May 2004, and the XXIInd Congress of the European Society of Cataract & Refractive Surgeons, Paris, France, September 2004.

☆☆ Supported in part by a grant from Research to Prevent Blindness Inc., New York, New York, to the Department of Ophthalmology and Visual Sciences, University of Utah, Salt Lake City, Utah, and by the ASCRS Cataract Clinical Committee.

 None of the authors has a proprietary or financial interest in any product mentioned.

PII: S0886-3350(04)00714-X

doi:10.1016/j.jcrs.2004.06.051


View previous. 63 of 73 View next.